Lv41
510 积分 2025-10-19 加入
A generative AI-discovered TNIK inhibitor for idiopathic pulmonary fibrosis: a randomized phase 2a trial
5小时前
已完结
Interleukin-6 as an Effective Intermediate Endpoint in Critical Illness: An Individual Patient Data Meta-analysis of Randomized Controlled Trials
5小时前
已关闭
INS018-055, A Novel Traf2- and NCK-interacting Kinase (TNIK) Inhibitor, Improves Lung Function in Patients With Idiopathic Pulmonary Fibrosis: Results From a Randomized, Double-blind, Placebo-controlled Phase 2a Study
6小时前
已完结
皖公网安备34019202002308
